| 000 | 01414 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513154038.0 | ||
| 264 | 0 | _c19981112 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0939-5555 | ||
| 024 | 7 |
_a10.1007/s002770050424 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRatei, R | |
| 245 | 0 | 0 |
_aImmunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cSep 1998 |
||
| 300 |
_a107-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aCell Lineage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLeukocyte Common Antigens _xblood |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSperling, C | |
| 700 | 1 | _aKarawajew, L | |
| 700 | 1 | _aSchott, G | |
| 700 | 1 | _aSchrappe, M | |
| 700 | 1 | _aHarbott, J | |
| 700 | 1 | _aRiehm, H | |
| 700 | 1 | _aLudwig, W D | |
| 773 | 0 |
_tAnnals of hematology _gvol. 77 _gno. 3 _gp. 107-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002770050424 _zAvailable from publisher's website |
| 999 |
_c9761531 _d9761531 |
||